Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
During persistent viral infections, chronic immune activation, negative immune regulator expression, an elevated interferon signature, and lymphoid tissue destruction correlate with disease progression. We demonstrated that blockade of type I interferon (IFN-I) signaling using an IFN-I receptor neutralizing antibody reduced immune system activation, decreased expression of negative immune regulatory molecules, and restored lymphoid architecture in mice persistently infected with lymphocytic choriomeningitis virus. IFN-I blockade before and after establishment of persistent virus infection resulted in enhanced virus clearance and was CD4 T cell-dependent. Hence, we demonstrate a direct causal link between IFN-I signaling, immune activation, negative immune regulator expression, lymphoid tissue disorganization, and virus persistence. Our results suggest that therapies targeting IFN-I may help control persistent virus infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, during viral infections, chronic type I and II IFN signaling can lead to immune suppression and a failure to clear viral infection.51-53”
From Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma (2021) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Restoring function in exhausted CD8 T cells during chronic viral infection
Barber, D. L., Wherry, E. J., Masopust, D., Zhu, B., Allison, J. P., Sharpe, A. H., Freeman, G. J., & Ahmed, R. (2006) · Nature · doi:10.1038/nature04444 · Cited by 3,986
Mechanisms of type-I- and type-II-interferon-mediated signalling
Platanias, L. C. (2005) · Nature Reviews Immunology · doi:10.1038/nri1604 · Cited by 3,491
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
A diverse range of gene products are effectors of the type I interferon antiviral response
Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M. (2011) · Nature · doi:10.1038/nature09907 · Cited by 2,433
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Interferon-stimulated genes and their antiviral effector functions
Schoggins, J. W., & Rice, C. M. (2011) · Current Opinion in Virology · doi:10.1016/j.coviro.2011.10.008 · Cited by 1,289
Type I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,195
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Interleukin-10 determines viral clearance or persistence in vivo
Brooks, D. G., Trifilo, M. J., Edelmann, K. H., Teyton, L., McGavern, D. B., & Oldstone, M. B. A. (2006) · Nature Medicine · doi:10.1038/nm1492 · Cited by 923
Self-citationIMMUNOBIOLOGY AND PATHOGENESIS OF VIRAL HEPATITIS
Guidotti, L. G., & Chisari, F. V. (2006) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.1.110304.100230 · Cited by 811
Cited by
Items 601–700 of 759
Chartrand, K., Lebel, M., Tarrab, E., Savard, P. E., Leclerc, D., & Lamarre, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01885 · Cited by 4
“Proc Natl Acad Sci U S A (2003) 100(11):6646–51.”
AISF position paper on HCV in immunocompromised patients
Marzano, A., Angelucci, E., Astegiano, M., Baratelli, C., Biancone, L., Bironzo, P., Brancaccio, G., Brunetto, M. R., Bruno, R., Burra, P., et al. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.09.022 · Cited by 4
“Recent reports have raised warning on the possible event of HBV reactivation among HCV-coinfected patients undergoing DAAs therapy [11], leading to transaminase flares and even fulminant hepatic failure.”
BackgroundKrólik, M., Csepregi, L., Hartmann, F., Engetschwiler, C., & Flatz, L. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.01.047 · Cited by 4
Takaoka, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820649-2.00115-7 · Cited by 4
Wang, L., Gao, Y., Zhang, Z., Pan, C.-K., Wang, Y., Zhu, Y.-C., Qi, Y.-P., Xie, F., Du, X., Li, N., et al. (2022) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i23.8161 · Cited by 4
Inactivation of Type I IFN Jak-STAT Pathway in EBV Latency
Wang, L. (2016) · Cancer Biology & Treatment · doi:10.24966/cbt-7546/100009 · Cited by 4
“At the early stage of infection, robust IFN-I response leads to a potent antiviral activity; meanwhile, it facilitates the establishment and maintenance of persistent infection by inducing the immune exhaustion program [20-21].”
BackgroundModulation of SIV and HIV DNA Vaccine Immunity by Fas-FasL Signaling
Yan, J., Zapata, J. C., Pauza, C. D., & Salvato, M. S. (2015) · Viruses · doi:10.3390/v7031429 · Cited by 4
“not significantly influenced, we speculate that cFLIP and FADD may modulate the innate immunity to fight the infection, as it has been reported that blocking type I interferon helps control chronic LCMV infection [52,53].”
BackgroundBhattacharya, B., Chattrerjee, S., Berland, R., Pichugin, A., Gao, Y., Connor, J. H., Ivanov, A., Yan, B.-S., Kobzik, L., & Kramnik, I. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/238873 · Cited by 4
Antigenic cancer persister cells survive direct T cell attackPreprint
Wang, M., Mauch, B. E., Williams, A. F., Barazande-Pour, T., Hoffmann, F. A., Harris, S. H., Lathrop, C. P., Turkal, C. E., Yung, B. S., Paw, M. H., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.03.14.643359 · Cited by 4
Jacob, R. A., Ajoge, H. O., D’Agostino, M. R., Shigayeva, A., Banerjee, A., Miller, M. S., McGeer, A., Mubareka, S., & Mossman, K. L. (2025) · npj Viruses · doi:10.1038/s44298-025-00149-2 · Cited by 3
LCMV-mediated loss of virtual memory CD8 T cells yields a functionally enhanced T cell subset
Hussain, T., Nguyen, A., Thiele, D., Kannangara, D., Huang, Z., Pang, E. S., Kirn, A., Bedoui, S., Good‐Jacobson, K. L., O’Keeffe, M. A., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113893 · Cited by 4
“33 Indeed, type I IFN-mediated death of CD8 T cells in the first two days after LCMV infection has been documented previously, 44–47 with blockade of type I IFNs rescuing CD8 T cells from apoptosis.”
InfluentialImmune-chemo combination therapy using doxorubicin/viral epitope Pluronic nanoparticles
Kil, Y. C., Kim, Y. G., Choi, A., Kim, J. Y., Park, S. J., Byun, Y., Jung, Y. W., & Yuk, S. H. (2025) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-025-00781-3 · Cited by 3
“LCMV GP (33–41) provides pathogen-associated molecular patterns (PAMPs) that ligate pattern-recognition receptors (Teijaro et al. 2013 ), while DOX triggers immunogenic cell death marked by calreticulin exposure and HMGB1 release (Zhou et al. 2019 ).”
Hu, Z., Abdelrahman, H., Elwy, A., Kuang, F., Dhiman, S., Ali, S., Marson, M., Holnsteiner, L., Hamdan, T. A., Friebus‐Kardash, J., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1638403 · Cited by 4
From host to population: Bridging the viral immuno-evolutionary gap
Jamaleddine, H., Grenfell, B. T., Graham, A. L., & Mandl, J. N. (2025) · Immunity · doi:10.1016/j.immuni.2025.12.001 · Cited by 3
Lyadova, I. V. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1717370 · Cited by 3
“I promoted IL – 10 and PD – L1 expressions (295).”
Oncolytic viral therapy under type I interferon regulation: Mathematical modeling and analysis
Ambegoda, P., Wei, H., & Jang, S. R. ‐. (2026) · Mathematical Biosciences · doi:10.1016/j.mbs.2026.109677 · Cited by 3
The JAK/STAT Pathway in Cancer: From Molecular Mechanisms to Clinical Applications
Liao, Y., Wei, Q., Song, H., Zeng, H., Qi, C., Meng, Y., Zhang, Y., Zhang, Y., Li, W., Li, Y., et al. (2026) · MedComm – Oncology · doi:10.1002/mog2.70063 · Cited by 4
Zhao, G., Korva, M., Muñoz‐Fontela, C., Günther, S., Kerber, R., Binder, S. C., & Meyer‐Hermann, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1806697 · Cited by 3
Honce, R., & Botten, J. (2026) · Journal of Virology · doi:10.1128/jvi.01751-25 · Cited by 3
Abdel–Haq, H. (2024) · Vaccines · doi:10.3390/vaccines12060583 · Cited by 3
“Using IFNAR-blocking antibodies [144–146] or targeting negative regulators of type I IFNs, including OASL1, USP18 and ISG-15 [161–163], has been proposed as a strategy against the viral persistence phenomenon.”
BackgroundMethodMizobuchi, H., Yamagishi, J., Sanjoba, C., & Goto, Y. (2025) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0012650 · Cited by 3
A Bloody Mess: Dendritic Cells Use Hemophagocytosis to Regulate Viral Inflammation
Miller, E., & Bhardwaj, N. (2013) · Immunity · doi:10.1016/j.immuni.2013.08.024 · Cited by 3
“Moreover, IL-10R and type I interferon receptor (IFNAR1) blockade in the persistent phase of LCMV infection has been shown to improve viral control and decrease T cell exhaustion in the case of IL-10 neutralization (Teijaro et al., 2013, Brooks et al., 2006).”
BackgroundIdentification of Candidate Predictors of Lupus Flare.
Crow, M. K., Olferiev, M., & Kirou, K. A. (2015) · Europe PMC (PubMed Central) · Cited by 4
Fernández-Sendin, M., Trani, C. A. D., Bella, Á., Vásquez, M., Ardaiz, N., Gomar, C., Arrizabalaga, L., Ciordia, S., Corrales, F. J., Aranda, F., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.620283 · Cited by 3
Jelinski, J., Kowatsch, M. M., Lafrance, M.-A., Berger, A., Pedersen, J., Azizi, H., Li, Y., Scholte, F. E. M., Gómez, A., Hollett, N. A., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2251595 · Cited by 3
Wong, D., Wilkins, P. A., & Landolt, G. A. (2024) · Wiley eBooks · doi:10.1002/9781119617228.ch50 · Cited by 3
Emission engineering in microdisk lasers via direct integration of meta‐micromirrors
Yu, A., Kim, M., Song, D. I., Park, B. J., Jeong, H. R., You, B. U., Jeon, S., Han, S.-W., & Kim, M. (2024) · Nanophotonics · doi:10.1515/nanoph-2023-0898 · Cited by 3
An Odyssey to Viral Pathogenesis
Oldstone, M. B. A. (2015) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044107 · Cited by 3
Self-citationLi, J. Y. Y. (2013) · Journal of Bioanalysis & Biomedicine · doi:10.4172/1948-593x.1000e121 · Cited by 3
Iwasaki, M., Ng, C. T., Cubitt, B., & de la Torre, J. C. (2016) · Journal of Virology · doi:10.1128/jvi.01303-16 · Cited by 3
“Unlike the situation observed in cultured cells, mice infected with Cl-13 exhibit high levels of IFN-I at early times of infection, which has been shown to contribute to establishment of Cl-13 persistence (39).”
BackgroundInfluentialSelf-citationThe Different Modes of Resistance to AIDS
Chakrabarti, L. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-404734-1.00015-2 · Cited by 3
Transition of T Cells from Effector to Memory Phase
Schauder, D., & Cui, W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.08013-9 · Cited by 4
STAT1-dependent tolerance of intestinal viral infectionPreprint
Filyk, H. A., Sharon, A. J., Fonseca, N. M., Simister, R. L., Yuen, W., Hardman, B. K., Robinson, H. G., Seo, J. H., Rocha‐Pereira, J., Welch, I. D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.13.936252 · Cited by 3
ISG15 drives immune pathology and respiratory failure during viral infectionPreprint
Shaabani, N., Žák, J., Johnson, J. L., Huang, Z., Nguyen, N., Lazar, D. C., Vartabedian, V. F., Honke, N., Prinz, M., Knobeloch, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.13.039321 · Cited by 3
“Despite the central role of IFN-I in promoting an antiviral state, deleterious consequences of IFN-I signaling during viral infection have been reported (Ng et al., 2015; Shaabani et al., 2018; Teijaro et al., 2013; Wilson et al., 2013).”
BackgroundSelf-citationAgonistic anti-CD40 converts Tregs into Type 1 effectors within the tumor micro-environmentPreprint
Maltez, V. I., Arora, C., Sor, R., Lian, Q., Vonderheide, R. H., Germain, R. N., & Byrne, K. T. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.17.512537 · Cited by 3
Liang, Q., Wang, L., Xu, J., Lin, A., Wu, Y., Tao, Q., Zhang, B., Min, H., Song, S., & Gao, Q. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01518-7 · Cited by 2
Suvieri, C., Mondanelli, G., Orabona, C., Pallotta, M. T., Panfili, E., Rossini, S., Volpi, C., & Belladonna, M. L. (2024) · Cells · doi:10.3390/cells13131088 · Cited by 2
“Nevertheless, the belief that these cytokines are endowed with an antiviral effect has been recently revised based on multiple pieces of evidence suggesting that prolonged type I IFN secretion rather suppresses the immune system and thus promotes viral persistence [3].”
BackgroundType I interferon production in myeloid cells is regulated by factors independent of Ptpn22
Barnes, J., Shaikh, A. F., Bevis, A. M., Cockerham, T., & Orozco, R. C. (2025) · ImmunoHorizons · doi:10.1093/immhor/vlaf063 · Cited by 2
Vijayamahantesh, V., He, Y., Jiang, L., Huerter, H., Jung, K. I., McKenna, S., Studstill, C. J., Allen, L. H., Nistala, R., Xu, D. H., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1706967 · Cited by 2
Laulhé, X., Adda-Bouchard, Y., Lopez, G., Chamberlain, G., Dubreuil, A., Charpentier, T., & Lamarre, A. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117145 · Cited by 2
Arsenio, J., Kahia, N., Robertson, S., Rodriguez, M., Layug, P. J., Vats, H., Kannan, K., Spicer, V., Ozturk-Aptekmann, A., & Wilkins, O. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783098 · Cited by 2
“LCMV-clone 13 infection leads to higher circulating levels of type I IFNs 24 hrs. post-infection and higher frequencies of infected plasmacytoid dendritic cells (pDCs) compared to LCMV-Armstrong (76, 77).”
Who Defends the Stem Cell’s Citadel?
Strick‐Marchand, H., & Durantel, D. (2018) · Cell stem cell · doi:10.1016/j.stem.2018.02.007 · Cited by 2
Bhattacharyya, M., & Penaloza‐MacMaster, P. (2018) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0251 · Cited by 2
“Prior reports have demonstrated that immune exhaustion during chronic infections and cancers can be partially reverted with checkpoint blockade, costimulation triggering,(16) T regulatory cell depletion,(17,18) cytokine modulation, or interferon blockade.(23,24) However, it is unknown whether hematopoietic transplanta…”
BackgroundNennig, K., Murthy, S., Maloney, S., Shaw, T. M., Sharobim, M., Matkovic, E., Fadiran, S., Larsen, M., Ramuta, M. D., Kim, A. S., et al. (2024) · PLOS Pathogens · doi:10.1371/journal.ppat.1012436 · Cited by 2
Self-citationSepahpour, T., Alshaweesh, J., Azodi, N., Singh, K., Ireland, D. D. C., Valanezhad, F., Nakamura, R., Satoskar, A. R., Dey, R., Hamano, S., et al. (2024) · npj Vaccines · doi:10.1038/s41541-024-01032-6 · Cited by 2
Les cellules dendritiques plasmacytoïdes : nouvel Eldorado de la thérapie antivirale ?
Smith, N., & Herbeuval, J. (2015) · Biologie Aujourd hui · doi:10.1051/jbio/2015017 · Cited by 2
Lee, J., Kim, W. K., Kwon, E.-K., Kim, Y., Shin, H. M., Kim, D. H., Min, C.-K., Choi, J., Lee, W., Choi, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179094 · Cited by 2
Liu, Y.-Z., Han, D., Shi, D., Hong, B., Qian, Y., Wu, Z., Yao, S.-H., Tang, T.-M., Wang, M., Xu, X., et al. (2020) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i11.1216 · Cited by 2
Innate Immune Recognition of Hepatitis C Virus
Li, K. (2016) · Springer eBooks · doi:10.1007/978-4-431-56098-2_13 · Cited by 3
Editorial: NK cell reaping of Tfh cells: reckless slaughter or sensible pruning?
Brown, M. G., & Erickson, L. D. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4ce0415-175r · Cited by 2
“Thus, future studies will need to address how type I IFN signaling controls NK cell lysis and whether additional mechanisms may operate, as the extent of type I IFN signaling is a major determinant of LCMV persistence [7, 8].”
BackgroundRanti, D. L., Wang, A. Y., Daza, J., Bieber, C., Salomé, B., Merritt, E., Cavallo, J. A., Hegewisch-Solloa, E., Mace, E. M., Farkas, A. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.06.483198 · Cited by 4
“In settings of chronic infection, a host-target stalemate can occur due to persistently elevated interferon signaling, the blockage of which can reduce viral burden (11-13).”
BackgroundNEIL1 block IFN-β production and enhance vRNP function to facilitate influenza A virus proliferation
Zhang, H., Li, C., Sun, R., Zhang, X., Li, Z., Hua, D., Yin, B., Yang, L., Zhang, L., & Huang, J. (2024) · npj Viruses · doi:10.1038/s44298-024-00065-x · Cited by 1
Li, S., Xin, J., Peng, Y., Liu, H., Zhou, Z., Zhong, Z., Fu, H., Yang, M., Li, W., Wu, R., et al. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1536913 · Cited by 1
Wang, Y., Wang, D., Yu, K., & Zhang, H. (2025) · Critical Public Health · doi:10.1080/09581596.2025.2574958 · Cited by 1
“…tumor necrosis factor pathways, and iFN-mediated upregulation of negative immune regulators weakening t-cell responses (channappanavar et al., 2016; teijaro et al., 2013). consequently, progressive lymphopenia is a recognized indicator of cellular immune deficiency and disease progression (li et…”
Zabiegala, A., Kim, Y., & Chang, K. (2025) · Virology · doi:10.1016/j.virol.2025.110734 · Cited by 3
Targeting the pDC/IFN-I axis in HIV-1 immunotherapy
Su, L., Ahodantin, J., & Li, G. (2025) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000998 · Cited by 3
Kim, A. S., Ma, K., Reinhardt, C. J., Lazar, D. C., Ogasawara, D., Shaw, T. M., de la Torre, J. C., Bailey, A. L., Melillo, B. N., Teijaro, J. R., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2524108123 · Cited by 1
“Lymphocytic choriomeningitis virus (LCMV clone 13 variant) was propagated in BHK - 21 cells and titered in Vero E6 cells (63).”
Self-citationHashimoto, M., Nasti, T. H., Jin, H.-T., Bu, M. T., Araki, K., Lee, J., Valanparambil, R. M., Akhtar, A., Khan, M. A., Peng, Z., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2427192123 · Cited by 1
“For instance, anti - IFNAR - 1 (MAR1 - 5A3, mIgG1), despite its intact Fc region and frequent use for blocking type I IFN activity in vivo (62, 63), shows limited depletion activity, likely due to the ubiquitous distribution of IFNAR - 1 - expressing cells (64).”
Perineural invasion: A neuroimmune axis mediating immunotherapy resistance across malignancies
Guo, J., Hu, Z., Wu, L., Liu, L., Li, Z., Xiong, L., & Yu, D. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116636 · Cited by 2
Nguyen, B. H., Stanley, E., Baxter, V. K., & Griffin, D. E. (2026) · Pathogens · doi:10.3390/pathogens15040441 · Cited by 1
“While the focus of this study looked at early stages in infection and innate immune response, it is also of interest to examine the effects of IFN β deficiency on the adaptive response, as IFN modulates T and B cell responses as well [20,37,38,91–94].”
Tenofovir, Interferon Pathways, and Mucosal Immunity: Implications for People Living With HIV
Hladik, F., Hughes, S. M., Levy, C., Creighton, R. L., Mackelprang, R. D., & Gornalusse, G. G. (2026) · American Journal of Reproductive Immunology · doi:10.1111/aji.70255 · Cited by 1
“However, persistent IFN-I signaling during chronic infection transitions from beneficial to detrimental [ 126, 127 ].”
The Role of and Therapeutic Strategies for Eosinophils in Atopic Dermatitis
Cheng, G., Sun, S., Deng, G., Luo, Y., Li, M., Zhao, H., Yang, X., Wang, R. L., Kuai, L., Zhang, Y., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14061212 · Cited by 1
“Teijaro, J. R. et al. [87] found that IFN-α signaling enhances IL-10 secretion (a key anti-inflammatory cytokine that suppresses eosinophil activation and survival) while directly inhibiting IL-5 transcription.”
Type I Interferons in Immune Defense Against Streptococci
Kovarik, P., Castiglia, V., & Janos, M. (2014) · Springer eBooks · doi:10.1007/978-3-319-09498-4_4 · Cited by 1
Traitement antiviral: Pour ou contre l’interféron de type I ?
Whitehead, P., Drouet, B., Zagury, D., & Bensussan, A. (2013) · médecine/sciences · doi:10.1051/medsci/20132910008 · Cited by 1
Iwasaki, M., Sharma, S. M., Marro, B. S., & de la Torre, J. C. (2017) · Virology · doi:10.1016/j.virol.2017.08.017 · Cited by 1
“Intriguingly, and in contrast to other viral infections, production of high levels of IFN-I at the early stages of LCMV infection seems to play a pro-viral role and promote the establishment of a chronic infection by the immunosuppressive strain clone 13 (Cl-13) of LCMV, as the blockade of IFN-I signaling results in t…”
Manske, K., Kallin, N., Bingsch, B., Steiger, K., Thimme, R., Knolle, P. A., & Wohlleber, D. (2018) · Journal of Hepatology · doi:10.1016/s0168-8278(18)31860-9 · Cited by 1
Alves-Peixoto, P., Férez, M., Knudson, C. J., Melo‐Silva, C. R., Stotesbury, C., Wong, E. B., Correia‐Neves, M., & Sigal, L. J. (2019) · Journal of Virology · doi:10.1128/jvi.01832-19 · Cited by 1
“IFN-I is important for the maintenance of chronic LCMV infection and T-cell dysfunction, because treatment with Abs to IFNAR accelerates recovery from chronic CL13 infection (10, 59).”
BackgroundIntegrating Context of Tumor Biology and Vaccine Design to Shape Multidimensional Immunotherapies
Wang, N. S., & Maine, C. J. (2020) · Future Drug Discovery · doi:10.4155/fdd-2019-0031 · Cited by 1
Soliman, E., Morsy, H., Othman, A., & Mady, A. M. (2020) · Minia Journal of Medical Research · doi:10.21608/mjmr.2022.217944 · Cited by 1
Khan, A. M., Steffensen, M. A., Paskeviciute, E., Abduljabar, A. B., Sørensen, T. L., Vorum, H., Nissen, M. H., & Honoré, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1374617 · Cited by 2
“LCMV, an enveloped RNA virus and the prototypic arenavirus, provides a suitable model system for investigating the mechanisms of acute and chronic viral infection, host – cell interactions, and pathogenesis (12, 13, 15, 16).”
Hahm, B. (2024) · Viruses · doi:10.3390/v16121939 · Cited by 1
“However, they could also cause inflammation or support T cell exhaustion in certain chronic viral infections [7,8], requiring in-depth interrogation of their mode of action.”
HIV-Associated Immune Exhaustion
Appay, V., Lissina, A., & Sauce, D. (2014) · Springer eBooks · doi:10.1007/978-1-4614-9610-6_186-1 · Cited by 1
“Master regulators of these pathways are likely to be type I interferons (Teijaro et al. 2013; Wilson et al. 2013), whose adverse role in chronic HIV infection appears increasingly evident.”
BackgroundPark, S. B. (2015) · eScholarship (California Digital Library)
The Role of Signal 3 Cytokine Timing in CD8 T Cell Activation: A Dissertation
Urban, S. L. (2015) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/m2wk5z
“animals and anti-IFNAR1 antibody blocking studies found reduced expression of inhibitory molecules, including IL-10 and programmed death-ligand 1 (PD-L1), resulting in viral clearance and restoration of exhausted T cells (9, 43-45).”
BackgroundEditorial Commentary: Who is “Special” Now?
Balagopal, A., & Thomas, D. L. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ382
Immune tolerance by interferon-alpha in experimental arthritis
Chalise, J. P. (2015) · Linköping University medical dissertations · doi:10.3384/diss.diva-122463
“Recent studies suggest that type I IFN can be detrimental for chronic viral infections, as blockage of type I IFN signalling resulted in effective clearance of persistent lymphocytic choriomeningitis virus (LCMV) (Teijaro et al., 2013, Wilson et al., 2013).”
BackgroundThe Anatomy of a Career in Science
Oldstone, M. B. A. (2016) · DNA and Cell Biology · doi:10.1089/dna.2016.3232
“Most recently, I have wondered why natural selection and evolution have yielded 14 type 1 IFNs that signal through the same heterodimeric receptor; that question prompted the mapping of precise roles for IFN type 1a and b (Teijaro et al., 2013; Ng et al., 2015).”
InfluentialSelf-citationNguyen, J. V. (2015) · OpenBU (Boston University)
Regulation of the germinal center response by T follicular helper cells and type I interferons
Dahlgren, M. W. (2016) · Lund University Publications (Lund University)
Innate Cytokine Responses and Their Functions during Viral Infections
Tarrio, M. L., & Biron, C. A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14005-6
Welsh, R. M., & Waggoner, S. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-374279-7.14007-x
Infectious Diseases in Transplantation—Report of the 20th Nantes Actualités Transplantation Meeting
Haspot, F., & Halary, F. A. (2015) · Transplantation · doi:10.1097/tp.0000000000000997
“Two recent publications in ‘Science’ showed that a persistent lymphocytic choriomeningitis virus infection can be impacted by neutralizing the IFN-I pathway with a subsequent expression of interferon-stimulated genes.(18,19) Based on these experimental observations, Alberto Sanchez-Fueyo and co-workers (London, UK) ha…”
BackgroundThe Role of Midbrain-Derived Neurotrophin-3 in Adult Mice: A Novel Factor for Mood Regulation
Shih, C. (2016) · DigitalGeorgetown (Georgetown University Library)
Fighting Chronic Neuroinflammation by Boosting Autoimmunity
Schwartz, M., & Baruch, K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801914-6.00013-1
Induction de la voie IFN/STAT1 dans le cancer du sein sous chimiothérapie : étude mécanistique
Gaston, J. (2016) · theses.fr (ABES) · doi:10.70675/f12f01b9z1813z4194z828cz931e4998f8d1
The T Cell Co-stimulatory Molecule GITR in the Control and Treatment of a Persistent Viral Infection
Clouthier, D. (2015) · TSpace (University of Toronto)
Mechanisms Underlying Plasmacytoid Dendritic Cell Regulation During Viral Infection
Smith, N., & Herbeuval, J. (2017) · Future Virology · doi:10.2217/fvl-2017-0052
Immune Plasticity in Chronic Hepatitis C Virus Patients Treated With Direct-Acting Antivirals
Aljabban, J. (2016) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Regulation of Anti-viral Immunity by Dendritic Cells and Natural Killer Cells
Mbanwi, A. N. (2015) · TSpace (University of Toronto)
Chang, Y.-H. (2016) · TSpace (University of Toronto) · Cited by 1
SRC FAMILY KINASE MEMBERS MEDIATE TYPE I INTERFERON PRODUCTION BY PLASMACYTOID DENDRITIC CELLS
Dallari, S. (2015) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/dallari-simone_phd2015-12-16
Wang, K. C. (2018) · TSpace (University of Toronto)
The Pathophysiology of Arthritis Due to Viruses and Vaccines
Reimold, A. M. (2019) · Springer eBooks · doi:10.1007/978-3-030-23311-2_9
Innate Immunity and Adenovirus Vector Immunization
Blass, E. (2018) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
The pathological significance of abnormal RON and PD-L1 expression in colorectal cancerPreprint
Liu, Y.-Z., Han, D., Shi, D., Hong, B., Qian, Y., Wu, Z., Yao, S.-H., Tang, T.-M., Xu, X.-M., Wang, M., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-37737/v1
Dysregulation of immune gene expression profiles during HTLV-1 infection
Keikha, M., Ali‐Hassanzadeh, M., Bagheri, R., & Karbalaei, M. (2021) · Meta Gene · doi:10.1016/j.mgene.2021.100944
Metadata
- Authors
- Teijaro, J. R., Ng, C., Lee, A. M., Sullivan, B. M., Sheehan, K. C. F., Welch, M., Schreiber, R. D., Carlos de la Torre, J., & Oldstone, M. B. A.
- Affiliations
- Scripps Research Institute (US)
- Washington University in St. Louis (US)
- Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA 92037, USA.
- Corresponding author
- Teijaro, John R.
- Ng, Cherie
- Oldstone, Michael B. A.
- ORCID
- Venue
- Science
- Published
- 2013-04-12
- Volume
- 340
- Issue
- 6129
- Pages
- 207-211
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC3640797
- OpenAlex
- W2024556668
- Cited by
- 755
- References
- 38
- Citations by year
- 2026: 32 · 2025: 40 · 2024: 39 · 2023: 40 · 2022: 42 · 2021: 49 · 2020: 56 · 2019: 55 · 2018: 55 · 2017: 73 · 2016: 86 · 2015: 80 · 2014: 71 · 2013: 37
- FWCI
- 50.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5t32ns041219-10, 5t32ai007354-30)
- National Heart, Lung, and Blood Institute (HL007195, T32HL007195)
- National Cancer Institute (R01CA043059, CA-43059, R37CA043059)
- National Institute of Allergy and Infectious Diseases (AI-077719, AI09484, AI-047140, R01AI009484, AI007354, R01AI047140, T32-AI007354., R56AI077719, R01AI077719, U54AI057160)
- National Institute of Neurological Disorders and Stroke (T32-NS041219, NS-041219)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Keywords
- lymphocytic choriomeningitis virus, viral persistence, type I interferon signaling, immune activation, negative immune regulation, CD4+ T cells, viral clearance, antiviral therapy
- MeSH terms
- Animals, Antibodies, Viral, Arenaviridae Infections, Dendritic Cells, Female, Immune Tolerance, Interferon Type I, Lymphocytes, Lymphocytic choriomeningitis virus, Male, Mice, Inbred C57BL, Spleen, Viremia, Signal Transduction, CD4-Positive T-Lymphocytes, Cytokines, Interleukin-10, Mice, Receptor, Interferon alpha-beta, B7-H1 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.